Transgene Biotek Limited (BSE: 526139)
Health Care · Biotechnology · IN
Rs2.55
+3.24% today · -40.8% 1Y
Transgene Biotek Limited (BSE: 526139) operates in the Biotechnology industry within the Health Care sector. The company is valued at $2.04M.
Over the last twelve months the share price has lost 40.8%, trading between 1.83 and 4.35.
Tweenvest scores Transgene Biotek Limited across four factors: quality 37/100, value 65/100, growth 0/100. Its strongest factor is value.
526139 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.04M
- Revenue (TTM)
- $23.45K
- P/E
- —
- EPS
- -0.21
- Dividend yield
- —
- Beta (5Y)
- 0.97
- 52-week high
- Rs4.35
- 52-week low
- Rs1.83
- Avg volume (3M)
- —
- Shares outstanding
- 75.77M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| GeoVax Labs, Inc.NasdaqCM: GOVX | $2.17M | $0.24 | -15.20% |
| Propanc Biopharma, Inc.NasdaqCM: PPCB | $2.17M | $0.34 | -29.59% |
| HBL - Hadasit Bio-Holdings LtdTASE: HDST-M | $2.16M | ₪0.60 | — |
| CASI Pharmaceuticals, Inc.OTCPK: CASI.F | $2.06M | $0.10 | -9.00% |
| Kairos Pharma, Ltd.NYSEAM: KAPA | $2.04M | $0.60 | -25.79% |
| Oncology Pharma Inc.OTCPK: ONPH | $2.01M | $0.05 | +4.00% |
| Anatara Lifesciences LtdASX: ANR | $1.98M | AU$0.01 | -10.00% |
| Oragenics, Inc.NYSEAM: OGEN | $1.96M | $0.43 | -4.63% |
Figures last refreshed Oct 18, 2026.